ESR1 and neoplasm: Hormone-dependent tumours are identified by ERα overexpression, and while Tamoxifen mediates ER activity, downregulation of the receptor is associated with the transition to a more aggressive phenotype that does not respond to therapy, a common evasive strategy employed by tumour cells60.